SpringWorks Therapeutics

SpringWorks Therapeutics

6 open jobsBiotechnology Research

About SpringWorks Therapeutics

Industry

Biotechnology Research

Headquarters

100 Washington Blvd, Stamford, Connecticut 06902, US

Company size

201-500

Founded

2017

SpringWorks Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company operating in the biotechnology research industry, dedicated to improving the lives of patients with rare tumors. Founded in 2017 and headquartered at 100 Washington Blvd, Stamford, Connecticut 06902, US, the company employs more than 370 people. SpringWorks developed and commercializes the first and only FDA- and EC-approved medicine for adults with desmoid tumors, as well as the first and only FDA- and EC-approved treatment for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN). The company is committed to finding the answers people with rare tumors need, driven by scientific curiosity and a sense of urgency given the importance of its mission. SpringWorks values authenticity, recognizing that diverse backgrounds, cultures, styles, and abilities strengthen its ability to deliver meaningful solutions for patients.

Jobs at SpringWorks Therapeutics

Work arrangements

Based on 6 current openings

See all 6 SpringWorks Therapeutics jobs →

Hiring activity at SpringWorks Therapeutics

Last 30 daysRoughly unchanged

3jobs added

View current jobs

Last 30 days3 jobs

Previous 30 days5 jobs

Salaries at SpringWorks Therapeutics

Salary range estimated from 23 job postings published on Global Work AI in the last 90 days.

Salary range

$170k–$267kper year

Typical salary

$198,000per year

Related companies